Mercer Capital Advisers’s Quest Diagnostics DGX Stock Holding History

Mercer Capital Advisers’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-200	Closed	-$21K	–	199
2019 Q3	$21K	Sell	200 -250	-56%	-$25.7K	0.01%	172
2019 Q2	$46K	Sell	450 -450	-50%	-$43.2K	0.03%	149
2019 Q1	$81K	Sell	900 -176	-16%	-$15.3K	0.05%	125
2018 Q4	$90K	Hold	1,076	–	–	0.07%	120
2018 Q3	$116K	Hold	1,076	–	–	0.08%	113
2018 Q2	$118K	Hold	1,076	–	–	0.09%	114
2018 Q1	$108K	Hold	1,076	–	–	0.08%	117
2017 Q4	$106K	Hold	1,076	–	–	0.08%	118
2017 Q3	$101K	Hold	1,076	–	–	0.07%	124
2017 Q2	$120K	Hold	1,076	–	–	0.09%	116
2017 Q1	$106K	Hold	1,076	–	–	0.08%	121
2016 Q4	$99K	Hold	1,076	–	–	0.08%	121
2016 Q3	$91K	Hold	1,076	–	–	0.07%	128
2016 Q2	$88K	Hold	1,076	–	–	0.07%	125
2016 Q1	$77K	Hold	1,076	–	–	0.07%	124
2015 Q4	$77K	Hold	1,076	–	–	0.07%	127
2015 Q3	$66K	Hold	1,076	–	–	0.06%	136
2015 Q2	$78K	Hold	1,076	–	–	0.07%	135
2015 Q1	$83K	Hold	1,076	–	–	0.07%	133
2014 Q4	$72K	Buy	+1,076	New	+$67.9K	0.06%	139

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mercer Capital Advisers's DGX Position: Q4 2019 in Review

Mercer Capital Advisers sold out of Quest Diagnostics (DGX) in Q4 2019, closing a stake of 200 shares — an estimated $21K sold.

Mercer Capital Advisers first reported a position in DGX in Q4 2014 and held it in 20 quarters. The position peaked at $120K in Q2 2017. 712 funds tracked by Wall St. Rank hold DGX as of Q4 2019.

Mercer Capital Advisers reported no remaining Quest Diagnostics position as of Q4 2019 after selling out during the quarter.
Mercer Capital Advisers sold 200 Quest Diagnostics shares in Q4 2019, an estimated $21K.
Mercer Capital Advisers first reported a position in Quest Diagnostics in Q4 2014 and held it in 20 quarters.
Mercer Capital Advisers's Quest Diagnostics position peaked at $120K in Q2 2017.
712 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.

Based on Mercer Capital Advisers's 13F filing for Q4 2019, filed 24 Jan 2020.